Charts
|
TWE |
Re:
TWE TA chart
|
|
Inbuilt
|
60 |
25K |
3 |
18/08/20 |
18/08/20 |
Charts
|
60
|
25K
|
3
|
|
Charts
|
TWE |
Re:
TWE TA chart
|
|
Inbuilt
|
60 |
25K |
0 |
18/08/20 |
18/08/20 |
Charts
|
60
|
25K
|
0
|
|
Charts
|
TWE |
Re:
TWE TA chart
|
|
Inbuilt
|
60 |
25K |
0 |
18/08/20 |
18/08/20 |
Charts
|
60
|
25K
|
0
|
|
Charts
|
EOS |
Re:
EOS Charts
|
|
Inbuilt
|
2.6K |
1.7M |
2 |
17/08/20 |
17/08/20 |
Charts
|
2.6K
|
1.7M
|
2
|
|
ASX - By Stock
|
TWE |
Re:
Ann: 2020 Annual Results Investor and Analyst Presentation
|
|
Inbuilt
|
10 |
4.8K |
0 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
10
|
4.8K
|
0
|
|
ASX - By Stock
|
EOS |
Re:
EOS Motley Fool Article
|
|
Inbuilt
|
8 |
6.9K |
0 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
8
|
6.9K
|
0
|
|
Charts
|
EOS |
Re:
EOS Charts
|
|
Inbuilt
|
2.6K |
1.7M |
0 |
12/08/20 |
12/08/20 |
Charts
|
2.6K
|
1.7M
|
0
|
|
Charts
|
EOS |
Re:
EOS Charts
|
|
Inbuilt
|
2.6K |
1.7M |
0 |
12/08/20 |
12/08/20 |
Charts
|
2.6K
|
1.7M
|
0
|
|
ASX - By Stock
|
ARX |
Re:
Undervalued IPO with FDA / CE certified product
|
|
Inbuilt
|
79 |
34K |
0 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
79
|
34K
|
0
|
|
Charts
|
EOS |
Re:
EOS Charts
|
|
Inbuilt
|
2.6K |
1.7M |
0 |
11/08/20 |
11/08/20 |
Charts
|
2.6K
|
1.7M
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
Inbuilt
|
461 |
302K |
1 |
11/08/20 |
11/08/20 |
Charts
|
461
|
302K
|
1
|
|
Charts
|
GXY |
Re:
Chart
|
|
Inbuilt
|
23K |
18M |
1 |
06/08/20 |
06/08/20 |
Charts
|
23K
|
18M
|
1
|
|
ASX - By Stock
|
EOS |
Re:
EOS - Shorts Target - Short Term
|
|
Inbuilt
|
37 |
19K |
1 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
37
|
19K
|
1
|
|
ASX - By Stock
|
EOS |
Re:
EOS - Shorts Target - Short Term
|
|
Inbuilt
|
37 |
19K |
0 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
37
|
19K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Placement and Share Purchase Plan
|
|
Inbuilt
|
200 |
58K |
1 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
200
|
58K
|
1
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
Inbuilt
|
461 |
302K |
1 |
06/08/20 |
06/08/20 |
Charts
|
461
|
302K
|
1
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
Inbuilt
|
461 |
302K |
0 |
05/08/20 |
05/08/20 |
Charts
|
461
|
302K
|
0
|
|
ASX - By Stock
|
EOS |
Re:
EOS - Shorts Target - Short Term
|
|
Inbuilt
|
37 |
19K |
1 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
37
|
19K
|
1
|
|
ASX - By Stock
|
EOS |
Re:
EOS - Shorts Target - Short Term
|
|
Inbuilt
|
37 |
19K |
2 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
37
|
19K
|
2
|
|
ASX - By Stock
|
LOV |
Re:
Ann: Business Update July 2020
|
|
Inbuilt
|
30 |
10K |
0 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
30
|
10K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Trading Halt
|
|
Inbuilt
|
77 |
30K |
0 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
77
|
30K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
Inbuilt
|
461 |
302K |
1 |
03/08/20 |
03/08/20 |
Charts
|
461
|
302K
|
1
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Trading Halt
|
|
Inbuilt
|
77 |
30K |
0 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
77
|
30K
|
0
|
|
ASX - By Stock
|
EOS |
Re:
EOS - Shorts Target - Short Term
|
|
Inbuilt
|
37 |
19K |
1 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
37
|
19K
|
1
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Trading Halt
|
|
Inbuilt
|
77 |
30K |
0 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
77
|
30K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Trading Halt
|
|
Inbuilt
|
77 |
30K |
4 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
77
|
30K
|
4
|
|
ASX - By Stock
|
ARX Medicine |
Re:
Great news
|
|
Inbuilt
|
34 |
16K |
1 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
34
|
16K
|
1
|
|
ASX - By Stock
|
ARX Medicine |
Re:
Great news
|
|
Inbuilt
|
34 |
16K |
1 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
34
|
16K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Investor Webinar - 30th July at 11am AEST
|
|
Inbuilt
|
26 |
6.6K |
2 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
26
|
6.6K
|
2
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Investor Webinar - 30th July at 11am AEST
|
|
Inbuilt
|
26 |
6.6K |
0 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
26
|
6.6K
|
0
|
|
ASX - By Stock
|
ARX Medicine |
Re:
Great news
|
|
Inbuilt
|
34 |
16K |
1 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
34
|
16K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Investor Webinar - 30th July at 11am AEST
|
|
Inbuilt
|
26 |
6.6K |
0 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
26
|
6.6K
|
0
|
|
ASX - By Stock
|
ARX |
Re:
Symphony a new product with FDA approval expected 2020
|
|
Inbuilt
|
4 |
1.1K |
1 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
4
|
1.1K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Symphony a new product with FDA approval expected 2020
|
|
Inbuilt
|
4 |
1.1K |
1 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
4
|
1.1K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Investor Webinar - 30th July at 11am AEST
|
|
Inbuilt
|
26 |
6.6K |
0 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
26
|
6.6K
|
0
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Investor Webinar - 30th July at 11am AEST
|
|
Inbuilt
|
26 |
6.6K |
1 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
26
|
6.6K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Undervalued IPO with FDA / CE certified product
|
|
Inbuilt
|
79 |
34K |
0 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
79
|
34K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
Ann: European Airport Trial Successful Deployment
|
|
Inbuilt
|
23 |
8.9K |
2 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
23
|
8.9K
|
2
|
|
ASX - By Stock
|
BUB |
Re:
Ann: Jennifer Hawkins Announced as Bubs Global Brand Ambassador
|
|
Inbuilt
|
100 |
43K |
2 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
100
|
43K
|
2
|
|
ASX - By Stock
|
EOS |
Re:
Ann: EOS in contract negotiations with Commonwealth Government
|
|
Inbuilt
|
343 |
166K |
0 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
343
|
166K
|
0
|
|
ASX - By Stock
|
LOV |
Re:
Ann: Business Update July 2020
|
|
Inbuilt
|
30 |
10K |
1 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
30
|
10K
|
1
|
|
ASX - By Stock
|
EOS |
Re:
$270b Defence spend. Large allocations to weapons and Space
|
|
Inbuilt
|
71 |
26K |
0 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
71
|
26K
|
0
|
|
ASX - By Stock
|
EOS |
Re:
$270b Defence spend. Large allocations to weapons and Space
|
|
Inbuilt
|
71 |
26K |
1 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
71
|
26K
|
1
|
|
ASX - By Stock
|
LOV |
Re:
Ann: Business Update
|
|
Inbuilt
|
40 |
18K |
0 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
40
|
18K
|
0
|
|
ASX - By Stock
|
LOV |
Re:
Ann: Business Update
|
|
Inbuilt
|
40 |
18K |
5 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
40
|
18K
|
5
|
|
ASX - By Stock
|
LOV |
Re:
Ann: Business Update
|
|
Inbuilt
|
40 |
18K |
0 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
40
|
18K
|
0
|
|
ASX - By Stock
|
WFE |
Re:
Researching WFE
|
|
Inbuilt
|
1.9K |
3.1M |
0 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
1.9K
|
3.1M
|
0
|
|
ASX - By Stock
|
LVT |
Re:
Ann: Q2 ARR grows to $52.7 million
|
|
Inbuilt
|
190 |
122K |
0 |
22/01/20 |
22/01/20 |
ASX - By Stock
|
190
|
122K
|
0
|
|
ASX - By Stock
|
REG |
Re:
News: REG Regis Healthcare Cuts FY20 Guidance
|
|
Inbuilt
|
7 |
12K |
1 |
23/12/19 |
23/12/19 |
ASX - By Stock
|
7
|
12K
|
1
|
|
ASX - By Stock
|
BLD |
Re:
Takeover target
|
|
Inbuilt
|
11 |
5.4K |
1 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
11
|
5.4K
|
1
|
|